Brief: Talaris Therapeutics Announces Q2 Loss Per Share Of $0.41

Tourmaline Bio

12/08/2021 12:36

Aug 12 (Reuters) - Talaris Therapeutics Inc  TALS.O :
    * TALARIS THERAPEUTICS ANNOUNCES SECOND QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * Q2 LOSS PER SHARE $0.41
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.26 -- REFINITIV IBES
DATA
    * FINISHED Q2 OF 2021 WITH $266.2 MILLION IN CASH, CASH
EQUIVALENTS AND MARKETABLE SECURITIES
    * CURRENT CASH AND CASH EQUIVALENTS ARE EXPECTED TO FUND
PIPELINE
DEVELOPMENT AND OPERATIONS INTO 2025

Source text for Eikon:  ID:nGNX9Dp5QL 
Further company coverage:  TALS.O 

 ((Reuters.Briefs@thomsonreuters.com;))